NASDAQ
Kronos Bio, Inc. (KRON) has a free cash flow growth of -0.02% as of Friday, May 29, 2026. This represents a 100.16% decrease compared to its 12-month average of 14.18%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.